Utility of MuSK antibodies in patients with myastenia gravis
Pichon-Riviere A, Augustovski F, Garcia Marti S, Bardach A, Galante J, Lopez A, Regueiro A, Glujovsky D, Aruj P, Calcagno J
Record ID 32009100166
Spanish
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.iecs.org.ar/iecs-visor-publicacion.php?cod_publicacion=1049&origen_publicacion=publicaciones
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Immunosuppressive Agents
- Myasthenia Gravis
- Receptor Protein-Tyrosine Kinases
- Treatment Outcome
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.